AR046870A1 - DERIVATIVES OF TETRAHYDRONAFTALENO AS ACTIVATING LINKS OF RAR RECEPTORS, THEIR USE IN HUMAN MEDICINE AS WELL AS COSMETICS AND PHARMACEUTICAL AND COSMETIC PREPARATIONS CONTAINING THEM. - Google Patents

DERIVATIVES OF TETRAHYDRONAFTALENO AS ACTIVATING LINKS OF RAR RECEPTORS, THEIR USE IN HUMAN MEDICINE AS WELL AS COSMETICS AND PHARMACEUTICAL AND COSMETIC PREPARATIONS CONTAINING THEM.

Info

Publication number
AR046870A1
AR046870A1 ARP040104542A ARP040104542A AR046870A1 AR 046870 A1 AR046870 A1 AR 046870A1 AR P040104542 A ARP040104542 A AR P040104542A AR P040104542 A ARP040104542 A AR P040104542A AR 046870 A1 AR046870 A1 AR 046870A1
Authority
AR
Argentina
Prior art keywords
radical
atom
hydrogen atom
branched
linear
Prior art date
Application number
ARP040104542A
Other languages
Spanish (es)
Inventor
Thibaud Biadatti
Olivier Roye
Original Assignee
Galderma Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma Res & Dev filed Critical Galderma Res & Dev
Publication of AR046870A1 publication Critical patent/AR046870A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/06—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted
    • C07C217/14—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring
    • C07C217/18—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C219/00—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C219/02—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C219/04—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C219/14—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the hydroxy groups esterified by a carboxylic acid having the esterifying carboxyl group bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C07C233/17—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/18—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C235/18—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the singly-bound oxygen atoms further bound to a carbon atom of a six-membered aromatic ring, e.g. phenoxyacetamides
    • C07C235/20—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the singly-bound oxygen atoms further bound to a carbon atom of a six-membered aromatic ring, e.g. phenoxyacetamides having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/62—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/192—Radicals derived from carboxylic acids from aromatic carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Dermatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Composiciones farmacéuticas destinadas a un uso en medicina humana o veterinaria, o incluso en composiciones cosméticas, con acción de ligandos activadores de los receptores RARs. Reivindicación 1: Compuestos caracterizados porque responden a la fórmula (1), en la cual: Ar representa un radical elegido entre los radicales del grupo de fórmulas (2); R1 representa un radical -OR3 o -NR4R5, R3, R4, y R5 tienen las significaciones dadas más adelante; R2 representa un átomo de hidrógeno, de flúor, de cloro, un radical metilo o un radical OR6, R6 tiene las significaciones dadas más adelante; R3 representa un átomo de hidrógeno, un radical alquilo lineal o ramificado, C1-20, un radical mono- o polihidroxialquilo C1-20, un radical monoaminoalquilo C1-20, o un residuo de azúcar; R4, R5, idénticos o diferentes, representan un átomo de hidrógeno, un radical hidroxi, un radical alquilo C1-6, lineal o ramificado, un radical mono- o polihidroxialquilo C1-20, o R4 y R5 forman con el nitrógeno de la estructura general, un residuo de aminoácido o un residuo peptídico, o bien, R4 y R5 tomados en forma conjunta, forman un heterociclo; R6 representa un átomo de hidrógeno, un radical metilo o un radical acetilo; R7 representa un radical CF3 o metilo; r', r'', idénticos o diferentes, representan un átomo de hidrógeno, un radical alquilo lineal o ramificado o cíclico C1-4, un radical (C=O)R7, o bien, r', r'' tomados en forma conjunta, forman un heterociclo pirrolidina o piperidina, R7 tiene las significaciones anteriores; A representa un átomo de oxígeno o un átomo de azufre; n es un entero comprendido entre 1 y 4; W representa un radical -CH2-; Y representa un átomo de oxígeno o un átomo de azufre, y las sales de los compuestos de fórmula (1) cuando R1 representa una función OH, así como los isómeros ópticos y geométricos de dichos compuestos de fórmula (1).Pharmaceutical compositions intended for use in human or veterinary medicine, or even in cosmetic compositions, with action of activating ligands of the RAR receptors. Claim 1: Compounds characterized in that they respond to formula (1), in which: Ar represents a radical chosen from the radicals of the group of formulas (2); R1 represents a radical -OR3 or -NR4R5, R3, R4, and R5 have the meanings given below; R2 represents a hydrogen, fluorine, chlorine atom, a methyl radical or an OR6 radical, R6 has the meanings given below; R3 represents a hydrogen atom, a linear or branched C1-20 alkyl radical, a C1-20 mono- or polyhydroxyalkyl radical, a C1-20 monoaminoalkyl radical, or a sugar residue; R4, R5, identical or different, represent a hydrogen atom, a hydroxy radical, a C1-6 alkyl radical, linear or branched, a mono- or polyhydroxyalkyl C1-20 radical, or R4 and R5 form with the nitrogen of the structure generally, an amino acid residue or a peptide residue, or R4 and R5 taken together, form a heterocycle; R6 represents a hydrogen atom, a methyl radical or an acetyl radical; R7 represents a CF3 or methyl radical; r ', r' ', identical or different, represent a hydrogen atom, a linear or branched C1-4 cyclic alkyl radical, a radical (C = O) R7, or, r', r '' taken in the form together, they form a heterocycle pyrrolidine or piperidine, R7 has the above meanings; A represents an oxygen atom or a sulfur atom; n is an integer between 1 and 4; W represents a radical -CH2-; Y represents an oxygen atom or a sulfur atom, and the salts of the compounds of formula (1) when R1 represents an OH function, as well as the optical and geometric isomers of said compounds of formula (1).

ARP040104542A 2003-12-08 2004-12-06 DERIVATIVES OF TETRAHYDRONAFTALENO AS ACTIVATING LINKS OF RAR RECEPTORS, THEIR USE IN HUMAN MEDICINE AS WELL AS COSMETICS AND PHARMACEUTICAL AND COSMETIC PREPARATIONS CONTAINING THEM. AR046870A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0314334A FR2863267B1 (en) 2003-12-08 2003-12-08 NEW RAR RECEPTOR ACTIVATOR LIGANDS, PROCESS FOR THEIR PREPARATION AND THEIR USE IN HUMAN MEDICINE AND COSMETICS

Publications (1)

Publication Number Publication Date
AR046870A1 true AR046870A1 (en) 2005-12-28

Family

ID=34586355

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP040104542A AR046870A1 (en) 2003-12-08 2004-12-06 DERIVATIVES OF TETRAHYDRONAFTALENO AS ACTIVATING LINKS OF RAR RECEPTORS, THEIR USE IN HUMAN MEDICINE AS WELL AS COSMETICS AND PHARMACEUTICAL AND COSMETIC PREPARATIONS CONTAINING THEM.

Country Status (2)

Country Link
AR (1) AR046870A1 (en)
FR (1) FR2863267B1 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2767525B1 (en) * 1997-08-21 1999-11-12 Cird Galderma BIPHENYL DERIVATIVES SUBSTITUTED BY AN AROMATIC OR HETEROAROMATIC RADICAL AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING THEM

Also Published As

Publication number Publication date
FR2863267B1 (en) 2006-07-14
FR2863267A1 (en) 2005-06-10

Similar Documents

Publication Publication Date Title
AR043279A1 (en) ANALOGS OF VITAMIN D, ITS USE, PHARMACEUTICAL COMPOSITION, COSMETIC COMPOSITION AND USE OF COSMETIC COMPOSITION
AR055297A1 (en) LIGANDOS MODULADORES OF THE RARS RECEIVERS, USE IN HUMAN MEDICINE AS WELL AS IN COSMETICS
ECSP078064A (en) NEW DERIVATIVES OF 2,4-DIANILINOPIRIMIDINAS, ITS PREPARATION, AS MEDICINES, PHARMACEUTICAL COMPOSITIONS AND MAINLY AS IKK INHIBITORS
CO6251270A2 (en) NEW DERIVATIVES OF 6-TRIAZOLOPIRIDACINA-SULFANIL BENZOTIAZOL AND BENCIMIDAZOL ITS PREPARATION PROCEDURE ITS APPLICATION AS MEDICINES PHARMACEUTICAL COMPOSITIONS AND NEW USE MAINLY AS MET INHIBITORS
AR061238A1 (en) HEPATITIS C PROTEASE INHIBITORS MACROCICLIC OXYLMYL COMPOUNDS
ES2781401T3 (en) Anti-wrinkle agents
PE20160548A1 (en) SULFONAMIDES AS SODIUM CHANNEL MODULATORS
UY33500A (en) Acyl sulfonamide derivatives and their pharmaceutically acceptable salts for use in medicine
ES2720957T3 (en) Process for pickling keratin fibers using a composition comprising a sulfinic acid derivative and an acidic aqueous composition
AR074895A1 (en) MODULATORS OF MELANOCORTINE RECEPTORS THEIR PREPARATION PROCEDURE AND ITS USE IN HUMAN MEDICINE AS WELL AS IN COSMETICS
PE20200698A1 (en) GEL INCLUDING CHLORHEXIDINE
ECSP088229A (en) DERIVATIVES OF PIRAZOLONA AS INHIBITORS OF 11-BETA HSD1
AR054341A1 (en) SYNERGIC COMBINATIONS OF FUNGICIDAL ACTIVE COMPOUNDS
SV2009003348A (en) NEW TRICYCLE DERIVATIVES, THEIR PREPARATION PROCEDURE AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT
AR092279A1 (en) PIRROL CARBOXAMIDAS FLUOROMETILO REPLACED
NI201000134A (en) NEW DIHYDROINDOLONE DERIVATIVES, THEIR PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
AR074454A1 (en) COMPOUNDS 4 - (- HETEROCICLOALQUIL) BENZENE-1,3-DIOL AS INHIBITORS OF THYROSINASE, AND ITS USE IN HUMAN MEDICINE AND ALSO IN COSMETICS
RU2017104882A (en) COMPOSITION OF FLUID FOR RINSING THE ORGANIC CAVITY CONTAINING A SOURCE OF PEROXIDE AND N-Acyl-L-ARGININE ALKYL ETHER SALT
AR050695A1 (en) BIAROMATIC COMPOUNDS ACTIVATING THE PPAR TYPE RECEIVERS AND THEIR USE IN COSMETIC OR PHARMACEUTICAL COMPOSITIONS
AR073089A1 (en) DERIVATIVES OF (POLI) AMINOALQUILAMINOALQUILAMIDAS, ALQUIL-UREA OR ALQUILSULFONAMIDA OF EPIPODOFILOTOXINA, A PROCESS TO PREPARE THEM, ITS APPLICATION IN THERAPY AS ANTICANCER AGENTS AND PHARMACEUTICAL COMPOSITION THAT CONTAIN THEM.
AR077694A1 (en) A LOW IRRITATION CLEANING COMPOSITION
CO6612211A2 (en) Amide derivative that has a hypoglycemic action and / or a protective action of b or pancreas cells
AR046871A1 (en) AROMATIC COMPOUNDS AS ACTIVATING LINKS OF RARS RECEPTORS, PHARMACEUTICAL AND COSMETIC COMPOSITIONS THAT CONTAIN THEM AND THEIR USE IN DERMATOLOGY.
AR046111A1 (en) DERIVATIVES OF BENZOIC ACID AS ACTIVATING LINKS OF RAR RECEIVERS AND ITS USE IN PHARMACEUTICAL COMPOSITIONS AS WELL AS ALSO IN COSMETICS.
AR046870A1 (en) DERIVATIVES OF TETRAHYDRONAFTALENO AS ACTIVATING LINKS OF RAR RECEPTORS, THEIR USE IN HUMAN MEDICINE AS WELL AS COSMETICS AND PHARMACEUTICAL AND COSMETIC PREPARATIONS CONTAINING THEM.

Legal Events

Date Code Title Description
FB Suspension of granting procedure